BNP Paribas Asset Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-238,015
| Closed | -$5.4M | – | 949 |
|
|
2018
Q2 | $5.4M | Buy |
238,015
+15,032
| +7% | +$341K | 0.05% | 463 |
|
|
2018
Q1 | $5.41M | Buy |
222,983
+46,791
| +27% | +$1.13M | 0.05% | 466 |
|
|
2017
Q4 | $4.91M | Buy |
176,192
+1,368
| +0.8% | +$38.2K | 0.04% | 491 |
|
|
2017
Q3 | $5.99M | Buy |
174,824
+12,069
| +7% | +$413K | 0.05% | 449 |
|
|
2017
Q2 | $6.48M | Buy |
+162,755
| New | +$6.48M | 0.06% | 437 |
|